| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 12, 2024 | Direct | ||
| Indaptus Therapeutics, Inc. | Director | Stock Option (right to buy) | 13.8K | Sep 30, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
| OBSV | ObsEva SA | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | Chief Executive Officer, Director |
| INDP | Indaptus Therapeutics, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 3, 2022 | Director |
| BOLT | Bolt Biotherapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| BOLT | Bolt Biotherapeutics, Inc. | Mar 24, 2022 | 2 | $0 | 4 | Mar 28, 2022 | Director |
| BOLT | Bolt Biotherapeutics, Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
| BOLT | Bolt Biotherapeutics, Inc. | Nov 17, 2021 | 0 | $0 | 3 | Nov 19, 2021 | Director |
| INDP | Indaptus Therapeutics, Inc. | Aug 4, 2021 | 1 | $0 | 4 | Aug 6, 2021 | Director |
| INDP | Indaptus Therapeutics, Inc. | Aug 3, 2021 | 0 | $0 | 3 | Aug 6, 2021 | Director |